Paramethadione

CHEMBL1100 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

157.2 g/mol

LogP

0.8

Phase

4

An anticonvulsant of the oxazolidinedione class previously used to treat absence (petit mal) seizures, now largely replaced by safer medications with fewer toxic effects. It works by reducing abnormal electrical activity in the brain.

Masse moléculaire

157,1700 g/mol

LogP

0,80

TPSA

46,60 Å²

Règle des 5 de Lipinski

Conforme

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCC1(C)OC(=O)N(C)C1=O

InChI

InChI=1S/C7H11NO3/c1-4-7(2)5(9)8(3)6(10)11-7/h4H2,1-3H3

Molecular Formula

C7H11NO3

HBD / HBA

- / 3

Liaisons Rotatives

1

Atomes Lourds

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

An anticonvulsant of the oxazolidinedione class previously used to treat absence (petit mal) seizures, now largely replaced by safer medications with fewer toxic effects. It works by reducing abnormal electrical activity in the brain.

Yes, Paramethadione is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1100. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 8280. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Paramethadione sur PillFYI

Structure

Données Clés

Formule: C7H11NO3

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.